Article

ZeptoCTC - Sensitive Protein Analysis of True Single Cell Lysates using Reverse Phase Protein Arrays (RPPA)

2023-09-16

Abstract excerpt

Circulating Tumor Cells (CTCs) are commonly analyzed through genomic profiling, which does not capture posttranslational and functional alterations of encoded proteins. To address this limitation, we developed ZeptoCTC, a single-cell protein analysis workflow that combines established technologies for single-cell isolation and sensitive Reverse Phase Protein Array (RPPA) analysis to assess multiple protein express...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8405763b-580d-5645-a39f-943a5633f323
DOI: 10.1101/2023.09.16.558042

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ZeptoCTC - Sensitive Protein Analysis of True Single Cell Lysates using Reverse Phase Protein Arrays (RPPA)DOI 10.1101/2023.09.16.558042Read

Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksSemantic proximity Read

Single-cell proteomics: potential implications for cancer diagnostics.Semantic proximity Read

Profiling protein expression in circulating tumour cells using microfluidic western blottingSemantic proximity Read

Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical ApplicationsSemantic proximity Read

Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimensSemantic proximity Read

A Reverse Phase Protein Array Based Phospho-antibody Characterization Approach and Its Applicability for Clinical Derived Tissue SpecimensSemantic proximity Read

Pan-cancer proteogenomic investigations identify post-transcriptional kinase targetsSemantic proximity Read

Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterizationSemantic proximity Read

Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncologySemantic proximity Read

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerSemantic proximity Read

TOPAS: phosphoproteome data analysis and decision support platform for molecular tumor boardsSemantic proximity Read

Pan-cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer TherapeuticsSemantic proximity Read